报道

订阅

MedSci主页 / 所有栏目 / 报道

预算削减威胁到抗菌素耐药性研究

2017-09-09 MedSci MedSci原创

预算削减抗菌素耐药
关注

据《内科学年鉴》9月4日发表的一篇文章称，拟议的预算削减可能会严重阻碍解决抗菌素耐药性（AMR）的努力。波士顿塔夫茨医疗中心的Helen W. Boucher博士及其同事们讨论了特朗普行政当局对抗菌药物耐药性的努力所产生的影响。作者写道，总统5月发布的预算请求将使美国疾病预防控制中心的AMR资金减少14％，并将其放在政府正在设法废除的预防和公共卫生基金内。预算还将削减国家过敏和传染病研究所的经费，

据《内科学年鉴》9月4日发表的一篇文章称，拟议的预算削减可能会严重阻碍解决抗菌素耐药性（AMR）的努力。波士顿塔夫茨医疗中心的Helen W. Boucher博士及其同事们讨论了特朗普行政当局对抗菌药物耐药性的努力所产生的影响。作者写道，总统5月发布的预算请求将使美国疾病预防控制中心的AMR资金减少14％，并将其放在政府正在设法废除的预防和公共卫生基金内。预算还将削减国家过敏和传染病研究所的经费，减少新的抗菌药物、诊断和疫苗的开发。此外，美国国际开发署的全球卫生计划削减了51%，这将大大削弱该机构支持抗菌药物管理和预防感染的能力。"在过去的两年里，我们国家的卫生专家和领导人一直在努力工作，以使美国能够正面应对AMR。"如果现在实施，这些提议的预算削减将扭转这一进程，这将违背专家的广泛共识，并对我们国家造成损害，"作者写道。原文出处：Helen W. Boucher. et.al， Proposed U.S. Funding Cuts Threaten Progress on Antimicrobial Resistance. Annals of Internal Medicine， 2

版权声明：
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料，版权均属于梅斯医学所有。非经授权，任何媒体、网站或个人不得转载，授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章，或“梅斯号”自媒体发布的文章，仅系出于传递更多信息之目的，本站仅负责审核内容合规，其内容不代表本站立场，本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系，我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2016205, encodeId=b15f2016205ee, content=<a href='/topic/show?id=7f2655e13cc' target=_blank style='color:#2F92EE;'>#抗菌素耐药性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=55713, encryptionId=7f2655e13cc, topicName=抗菌素耐药性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=daa8281, createdName=雕雕, createdTime=Tue Feb 20 22:00:00 CST 2018, time=2018-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1774894, encodeId=a7821e74894e7, content=<a href='/topic/show?id=e5ff55e11df' target=_blank style='color:#2F92EE;'>#抗菌素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=55711, encryptionId=e5ff55e11df, topicName=抗菌素)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aeef38715773, createdName=xiongke023, createdTime=Mon Oct 16 04:00:00 CST 2017, time=2017-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1330601, encodeId=33891330601f0, content=<a href='/topic/show?id=c6b455688d1' target=_blank style='color:#2F92EE;'>#抗菌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=55688, encryptionId=c6b455688d1, topicName=抗菌)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/qqapp/1103841572/2898B09F0DA89357D0D54A725E611AC7/100, createdBy=fdd32500040, createdName=ms7899726347904398, createdTime=Mon Sep 11 12:00:00 CST 2017, time=2017-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=242281, encodeId=034e24228127, content=谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Pw2csslt7CukWiabqiblnQAXaDEiaxhu025c3P0XshccTrbvGWBjKvnHIxbK3vqa80P7WGIFuicCFet97TicrNKpgB3TdabxP1vMh/0, createdBy=28851960965, createdName=榄枷檬, createdTime=Sat Sep 09 21:49:56 CST 2017, time=2017-09-09, status=1, ipAttribution=)]
    2018-02-20 雕雕

    #抗菌素耐药性#

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2016205, encodeId=b15f2016205ee, content=<a href='/topic/show?id=7f2655e13cc' target=_blank style='color:#2F92EE;'>#抗菌素耐药性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=55713, encryptionId=7f2655e13cc, topicName=抗菌素耐药性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=daa8281, createdName=雕雕, createdTime=Tue Feb 20 22:00:00 CST 2018, time=2018-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1774894, encodeId=a7821e74894e7, content=<a href='/topic/show?id=e5ff55e11df' target=_blank style='color:#2F92EE;'>#抗菌素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=55711, encryptionId=e5ff55e11df, topicName=抗菌素)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aeef38715773, createdName=xiongke023, createdTime=Mon Oct 16 04:00:00 CST 2017, time=2017-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1330601, encodeId=33891330601f0, content=<a href='/topic/show?id=c6b455688d1' target=_blank style='color:#2F92EE;'>#抗菌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=55688, encryptionId=c6b455688d1, topicName=抗菌)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/qqapp/1103841572/2898B09F0DA89357D0D54A725E611AC7/100, createdBy=fdd32500040, createdName=ms7899726347904398, createdTime=Mon Sep 11 12:00:00 CST 2017, time=2017-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=242281, encodeId=034e24228127, content=谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Pw2csslt7CukWiabqiblnQAXaDEiaxhu025c3P0XshccTrbvGWBjKvnHIxbK3vqa80P7WGIFuicCFet97TicrNKpgB3TdabxP1vMh/0, createdBy=28851960965, createdName=榄枷檬, createdTime=Sat Sep 09 21:49:56 CST 2017, time=2017-09-09, status=1, ipAttribution=)]
    2017-10-16 xiongke023

    #抗菌素#

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=2016205, encodeId=b15f2016205ee, content=<a href='/topic/show?id=7f2655e13cc' target=_blank style='color:#2F92EE;'>#抗菌素耐药性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=55713, encryptionId=7f2655e13cc, topicName=抗菌素耐药性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=daa8281, createdName=雕雕, createdTime=Tue Feb 20 22:00:00 CST 2018, time=2018-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1774894, encodeId=a7821e74894e7, content=<a href='/topic/show?id=e5ff55e11df' target=_blank style='color:#2F92EE;'>#抗菌素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=55711, encryptionId=e5ff55e11df, topicName=抗菌素)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aeef38715773, createdName=xiongke023, createdTime=Mon Oct 16 04:00:00 CST 2017, time=2017-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1330601, encodeId=33891330601f0, content=<a href='/topic/show?id=c6b455688d1' target=_blank style='color:#2F92EE;'>#抗菌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=55688, encryptionId=c6b455688d1, topicName=抗菌)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/qqapp/1103841572/2898B09F0DA89357D0D54A725E611AC7/100, createdBy=fdd32500040, createdName=ms7899726347904398, createdTime=Mon Sep 11 12:00:00 CST 2017, time=2017-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=242281, encodeId=034e24228127, content=谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Pw2csslt7CukWiabqiblnQAXaDEiaxhu025c3P0XshccTrbvGWBjKvnHIxbK3vqa80P7WGIFuicCFet97TicrNKpgB3TdabxP1vMh/0, createdBy=28851960965, createdName=榄枷檬, createdTime=Sat Sep 09 21:49:56 CST 2017, time=2017-09-09, status=1, ipAttribution=)]
    2017-09-11 ms7899726347904398

    #抗菌#

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=2016205, encodeId=b15f2016205ee, content=<a href='/topic/show?id=7f2655e13cc' target=_blank style='color:#2F92EE;'>#抗菌素耐药性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=55713, encryptionId=7f2655e13cc, topicName=抗菌素耐药性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=daa8281, createdName=雕雕, createdTime=Tue Feb 20 22:00:00 CST 2018, time=2018-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1774894, encodeId=a7821e74894e7, content=<a href='/topic/show?id=e5ff55e11df' target=_blank style='color:#2F92EE;'>#抗菌素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=55711, encryptionId=e5ff55e11df, topicName=抗菌素)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aeef38715773, createdName=xiongke023, createdTime=Mon Oct 16 04:00:00 CST 2017, time=2017-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1330601, encodeId=33891330601f0, content=<a href='/topic/show?id=c6b455688d1' target=_blank style='color:#2F92EE;'>#抗菌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=55688, encryptionId=c6b455688d1, topicName=抗菌)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/qqapp/1103841572/2898B09F0DA89357D0D54A725E611AC7/100, createdBy=fdd32500040, createdName=ms7899726347904398, createdTime=Mon Sep 11 12:00:00 CST 2017, time=2017-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=242281, encodeId=034e24228127, content=谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Pw2csslt7CukWiabqiblnQAXaDEiaxhu025c3P0XshccTrbvGWBjKvnHIxbK3vqa80P7WGIFuicCFet97TicrNKpgB3TdabxP1vMh/0, createdBy=28851960965, createdName=榄枷檬, createdTime=Sat Sep 09 21:49:56 CST 2017, time=2017-09-09, status=1, ipAttribution=)]
    2017-09-09 榄枷檬

    谢谢分享

    0